May 28, 2021 7:38am

The rush to the long holiday weekend goal

News: Biostage (BSTG) auditors walk away, even they escaped ...

https://www.regmedinvestors.com/articles/11932 

My version of the morning’s “indications” is about what you need to know; it’s what could happen or materialize after the opening and what might happen during the session

Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors! 

 


Dow futures are UP +0.51% (+175 points), S&P futures are UP +0.40% (+17 points) and NASDAQ futures are UP +0.39% (+54 points)

 

Stock futures point to a strong opening on Friday,

European markets advanced on Friday to notch record highs,

Asian Pacific markets rose as investors reacted to the market debut of JD Logistics in Hong Kong.

 

Data Docket: Personal Income and consumer spending will be released along with the PCE Core Price Index which is closely watched by the Fed for signs of inflation. The PCE is expected to have increased 2.9% in April year-over-year, according to economists.

 

Henry’omics:

Closing the week on solid note?

The S&P 500 is up 1.08% week to date, the Dow is 0.75% higher over the same time period, while the Nasdaq has gained nearly 2%.

 

RegMed/Cell and Gene Therapy Earnings Scorecard Q1/21 LPS Results … thirty (31) to date …  https://www.regmedinvestors.com/articles/11628

 

Thursday’s evening’s recap: “RegMed Investors’ (RMi) closing bell: sector stocks are rising in a relatively back and forth session. Low trading volume as anticipated, volatility helps the oversold while the Nasdaq faltered leading into the holiday weekend.” … https://www.regmedinvestors.com/articles/11931

  • The Nasdaq closed DOWN -1.72 points (-0.01%);
  • The IBB closed up +0.12% and XBI closed up +1.28%
  • Sector volume was LOW with 5 of the 19-upside having higher than the 3-month average volume with the volume of 2 of 13-downside having higher than the 3-month average volume;
  • The CBOE Volatility Index (VVIX: INDEX) was down -0.62 points or -3.57% at 16.74;
  • Thursday’s percentage (%) of the 19-upside were +0.46% (SGMO) to +5% (QURE) while the 13-downside ranges from -0.10% (CRSP) to -4.40% (CLLS);

Q2/21

May:  8 positive and 11 negative closes

April: 11 negative and 10 positive closes

Q1/21:

  • March: 10 positive, 12 negative and 1 neutral closes
  • February: 9 positive, 10 negative closes and 1 holiday
  • January: 10 positive, 9 negative closes and 1 holiday

 

Companies in my headlights – It’s your decision; I provide an idea and context:

The Biostage (BSTG) - Maintaining Sell

Biostage (BSTG) closed flat at $1.30 after being down -$0.21 to $1.11 with 5617 shares traded (the “pump and promote” was back) after Wednesdays at $1.30 again with 45 shares traded, Tuesday’s flat with 358 shares traded, Monday’s flat with 45 shares traded and last Friday’s +$0.02 to $1.32 with 299 shares traded and last Thursday at $1.30 with 1 share traded.

MINORITY PUBLIC shareholders are waiting, watching and weighing responses to MAINTAIN their RIGHTS.

 

The morning’s indications: I’m starting the Memorial weekend early and “sitting-out” this a.m. re forecasting indications – there is an … escapism in the market and sector.

 

The BOTTOM LINE: I STILL feel like a song from a broken record, “post earnings’ release, BUY some (few) short-term dips but, cautiously”.

My focus has always been “warning analysis” … my advice, trim and skim any new highs if one can!” I also see some lows that could be in the “pick-up” stock game.

My motto, never leave an investor uninformed about what I know!

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.